Himu Lukka

Juravinski Cancer Centre

Papers

1

Total Citations

16

H-Index

1

About

Himu Lukka is a leading figure in radiation oncology, whose work has fundamentally shaped the treatment of prostate cancer. His primary research focuses on the optimization of radiotherapy delivery, particularly through the technique of stereotactic body radiotherapy (SBRT). Dr. Lukka’s major contribution lies in rigorously evaluating the efficacy, resources, and cost-effectiveness of advanced technologies like robotic and arc-based systems for delivering high-dose, hypofractionated radiation. His seminal 2014 paper, "The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer," (16 citations) provides a critical framework for understanding how these modern systems compare to conventional fractionation regimens. This work is pivotal for clinicians and policymakers seeking to balance clinical outcomes with economic and logistical realities. By systematically analyzing the shift from standard 39-fraction regimens to shorter, more intense SBRT schedules, Dr. Lukka has helped pave the way for more convenient and potentially more effective prostate cancer care, making him a key voice in the evolution of modern radiation therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
The Technique, Resources and Costs of Stereotactic Body Radiotherapy of Prostate Cancer
16 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Juravinski Cancer Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago